Abstract
In this study conducted over a period of thirty months, 228 cases of mycotic keratitis were treated with ketoconazole, itraconazole or amphotericin B. This included 69 cases of Aspergillus keratitis. In general, severity of the keratitis influenced response to therapy with all three compounds. A positive correlation was made between age and response of Aspergillus keratitis to itraconazole. Aspergillus keratitis was found to respond more frequently to itraconazole than to ketoconazole or amphotericin B. Itraconazole was significantly superior to ketoconazole and apparently superior to amphotericin B in the treatment of severe Aspergillus keratitis. Although oral azole therapy was not associated with major drawbacks, topical azole therapy was frequently hampered by ocular irritation and inefficacy in treating severe keratitis. Itraconazole may emerge as the drug of choice in treating Aspergillus keratitis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Agarwal, L.P., Malik, S.R.K., Madan M. and Khosla P.K., 1963, Mycotic corneal ulcers, Brit. J. Ophthalmol., 47:109.
Ahuja, O.P., Lal, A., Hath, K. and Nema, H.V., 1967, Hamycin in experimental keratomycosis, J.All-India Ophthalmol. Soc., 15:19.
Anderson, B., Jr. and Chick, E.W. 1963, Mycokeratitis: Treatment of fungal corneal ulcers with Amphotericin B and mechanical debridement, Southern Med. J., 56:270.
Appalanarasayya, K., Rao, T.K.M., Reddy, E.E. and Rao, K.N.C., 1973, Fungal corneal ulcers, J. Indian Med. Asso., 60:206.
Arora, S. and Tyagi, S.C., 1976, Fungal flora of the conjunctival sac in health and disease, Ind. J. Ophthalmol., 24:15.
Balakrishnan, E., 1961, Mycotic keratitis caused by Aspergillus fumigatus, Brit. J. Ophthalmol., 45:828.
Chaddah, M.R. and Agarwal, D.C., 1978, Treatment of keratomycosis with Amphotericin B ointment, Ind. J. Ophthalmol., 26:9.
Das Gupta, L.R., Gupta, A.K., Ray, B.G., Sundaraj, T., Ramamurthy, S. and Lamba, P.A., 1973, Mycological studies in keratitis, Indian J. Med. Res., 61:165.
Dixon, D.M., Shadomy, S., Shadomy, H.J., Espinel-Ingroff, A. and Kerkering, T., 1978, Comparison of the in-vitro antifungal activities of Miconazole and a new imidazole, R 41400, J. Infect. Dis. 138:245.
Dutta, L.C., Dutta, D., Mohanty, P. and Sharma, J., 1981, Study of fungus keratitis, Ind. J. Ophthalmol., 29:407.
Ellison, A.C. and Newmark, E., 1973, Effects of subconjunctival pimaricin in experimental keratomycosis, Am. J. Ophthalmol., 75:790.
Emmons, C.W., Binford, H.C., Utz, J.P. and Kwon-Chung, K.J., 1977, “Medical Mycology” Lea and Febiger, Philadelphia.
Espinel-Ingroff, A., Shadomy, S. and Gebhart, R.J., 1984, In-vitro studies with R 51211 (Itraconazole), Antimicrob. Agents Chemother., 26:5.
Fitzsimons, R. and Peters, A.C., 1986, Miconazole and Ketoconazole as a satisfactory first-line treatment for keratomycosis, Am. J. Ophthalmol. 101:605.
Forster, R.K., 1983, Fungal diseases, in: “The Cornea: Scientific Foundations and Clinical Practice,” G. Smolin and R.A. Thoft, eds., Little Brown and Co., Boston, Toronto.
Foster, C.S., 1981, Miconazole therapy for keratomycosis, Am. J. Ophthalmol, 91: 622.
Foster, C.S., Lass, J.H., Moran-Wallace, K. and Giovanoni, R., 1981, Ocular toxicity of topical antifungal agents, Arch. Ophthalmol., 99:1081.
Gingrich, W.D., 1962, Keratomycosis, J.A.M.A., 179:662.
Havener, W.H., 1983, “Ocular Pharmacology”, C.V. Mosby Co., St. Louis.
Ivandic, T. and Genee, E., 1971, Clinical and animal experimental results using pima biciron, Rev. Med. Vet. Mycology, 9:1587.
Jones, B.R., 1975, Principles in the Management of Oculomycoses, Am. J. Ophthalmol, 79:719.
Jones, D.B., Sexton, R. and Rebell, G.,1969, Mycotic keratitis in South Florida: A review of 39 cases, Trans. Ophthal. Soc. U.K., 89:781.
Jones, D.B., Forster, R.K. and Rebell, G., 1972, Fusarium solanae keratitis treated with natamycin (Pimaricin). Arch. Ophthalmol., 88:147.
Jones. D.B., 1975, A plan for antimicrobial therapy in bacterial keratitis, Ophthalmology 79:95.
Kaufman, H.E. and Wood., R.M., 1965, Mycotic keratitis, Am. J. Ophthalmol., 59:993.
Komadina, T.G., Wilkes, T.D.I., Shock, J.P., Ulmes, W.C., Jackson, J. and Bradsher, R.W., 1985, Treatment of Aspergillus fumigatus keratitis in rabbits with oral and topical ketoconazole., Am. J. Ophthalmol., 99:476.
Kulshrestha, O.P., Bhargava, S. and Dube, M.K., 1973, Keratomycosis: A report of 23 cases, Ind. J. Ophthalmol., 21:51.
Montana, J.A. and Sery, T., 1958, Effect of fungistatic agents in corneal infection with Candida albicans, Arch. Ophthalmol., 60:1.
National Institute of Allergy and Infectious Diseases Mycoses Study Group, 1985, Treatment of blastomycosis and histoplasmosis with ketoconazole, Ann. Intern. Med. 103:861.
Nema, H.V., 1978, Keratomycosis in India, in: “XXIII Concilium Ophthalmologicum Kyoto 1978 Acta part II”, K. Shimizu and J.A. Oosterhuis, eds., Excerpta Medica, Amsterdam Oxford.
O’Day, D.M., 1984, Antifungal Agents, in: “Corneal Disorders: Clinical Diagnosis and Management” H.M. Leibowitz, ed., W.B. Saunders Co., Philadelphia.
O’Day, D.M., Ray, W.A., Head, W.S. and Robinson, R.D., 1984, Influence of the corneal epithelium on the efficacy of topical antifungal agents, Invest. Ophthalmol. Vis. Sci., 25:855.
Oji, E.O., 1982, Ketoconazole: A new imidazole agent has both prophylactic potential and therapeutic efficacy in keratomycosis of rabbits, Int. Ophthalmol., 95:342.
Puttana, S.T., 1969, Primary keratomycosis, J. All-India Ophthalmol. Soc., 17:171.
Sandhu, D.K. and Randhawa, I.S., 1979, Studies on the air-borne fungal spores in Amritsar and their role in keratomycosis, Mycopathologia, 68:47.
Shadomy, S., Espinel-Ingroff, A. and Kerkering, T.M., 1984, In vitro studies with four new antifungal agents: Bay n7133, bifonazole (BAY n4502), ICI 153 066 and RO 14-4767/002, Sabouraudia, 22:7.
Siva Reddy, P., Satyendran, O.M., Satpathy, M., Vijayakumar and Ranga Reddy, P., 1972, Mycotic keratitis, Ind. J. Ophthalmol., 20:101.
Sood, N.N., Ratanraj, A., Shaney, B.P. and Madhavan, H.N., 1968, Hypopyon ulcer — Clinical Study, Orient Arch.: Ophthalmol., 6:100.
Srivastava, O.P., Kaul, R.L. and Gupta, S.P., 1975, A survey of fungi from eye patients in Lucknow, Ind. J. Ophthalmol., 24:19.
Talwar, P. and Seghal, S.C., 1978, Mycotic infections of the eye in Chandigarh and neighbouring areas, Indian J. Med. Res., 67:929.
Thomas, P.A. and Rajasekaran, J., 1986, In-vitro susceptibility patterns of ocular fungal isolates, J. Madras State Ophthal. Assoc., 23:8.
Thomas, P.A., Kalavathy, C.M. and Rajasekaran, J., 1986, Microbial keratitis: A study of 774 cases and review of the literature, J. Madras State Ophthal. Assoc., 23:13.
Torack, R.M., 1957, Fungus infections associated with antibiotics and steroid therapy, Amer. J. Med., 22:872.
Torres, M.A., Mohammed, J., Cavazos-Adame, H. and Martinez, L.A., 1985, Topical ketoconazole for fungal keratitis, Am.J.Ophthalmol., 100:293.
Upadhayay, M.P., 1978, Fungal Infections of the Eyes, in: “XXIII Concilium Ophthalmologicum Kyoto 1978 Acta part II”, K. Shimizu and J.A. Oosterhius, eds., Excerpta Medica, Amsterdam Oxford.
Upadhayay, M.P., West, E.P. and Sharma, A.P., 1980, Keratitis due to Aspergillus flavus successfully treated with thiabendazole, Brit. J. Ophthalmol. 64:30.
Van Cutsem, J., Van Gerven, F., Van de Ven, M., Borgers, M. and Janssen, P.A.J., 1984, Itraconazole, a new triazole that is orally active in Aspergillosis, Antimicrob. Agents Chemother., 26:527.
Wood, T.O. and Williford, W., 1976, Treatment of keratomycosis with amphoterlcin B 0.15%, Am.J. Ophthalmol., 81:847.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Thomas, P.A., Rajasekaran, J. (1988). Treatment of Aspergillus Keratitis with Imidazoles and Related Compounds. In: Vanden Bossche, H., Mackenzie, D.W.R., Cauwenbergh, G. (eds) Aspergillus and Aspergillosis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3505-2_23
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3505-2_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-3507-6
Online ISBN: 978-1-4899-3505-2
eBook Packages: Springer Book Archive